Concepedia

Publication | Open Access

Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial

51

Citations

33

References

2017

Year

Abstract

In the first 12 weeks, volumetric methods did not provide significant improvement over the RANO criteria as a posttreatment prognostic marker.

References

YearCitations

Page 1